Skip to main content
Top

Cellular Oncology

Issue 3/2018

Content (8 Articles)

Review

The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications

Vignesh Sundararajan, Fazlul H. Sarkar, Thamil Selvee Ramasamy

Original Paper

Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer

Katarzyna Starska, Ewa Forma, Iwona Lewy-Trenda, Olga Stasikowska-Kanicka, Michał Skóra, Magdalena Bryś

Original Paper

Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior

Yu-Jie Dai, Yi-Bo Qiu, Rong Jiang, Man Xu, Ling-Yao Liao, George G. Chen, Zhi-Min Liu

Original Paper

Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1

Rosalba D’Alessandro, Maria Grazia Refolo, Catia Lippolis, Nicola Carella, Caterina Messa, Aldo Cavallini, Brian Irving Carr

Original Paper

Inhibition of autophagy enhances DENSpm-induced apoptosis in human colon cancer cells in a p53 independent manner

Ajda Coker Gurkan, Elif Damla Arisan, Pinar Obakan Yerlikaya, Halime Ilhan, Narcin Palavan Unsal

Open Access Original Paper

A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells

Eroje M. Ahmed, Gagori Bandopadhyay, Beth Coyle, Anna Grabowska

Report

Diagnostic and prognostic relevance of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral lichen planus - a short report

Masoumeh Mehdipour, Minoo Shahidi, Soheila Manifar, Soudeh Jafari, Fatemeh Mashhadi Abbas, Mahmood Barati, Hamed Mortazavi, Mohammad Shirkhoda, Amir Farzanegan, Zahra Elmi Rankohi

Commentary

Genetics of personalized medicine: cancer and rare diseases

Inês Teles Siefers Alves, Manuel Condinho, Sónia Custódio, Bruna F. Pereira, Rafael Fernandes, Vânia Gonçalves, Paulo J. da Costa, Rafaela Lacerda, Ana Rita Marques, Patrícia Martins-Dias, Gonçalo R. Nogueira, Ana Rita Neves, Patrícia Pinho, Raquel Rodrigues, Eva Rolo, Joana Silva, André Travessa, Rosário Pinto Leite, Ana Sousa, Luísa Romão

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine